A prospective study of renal structure and function in psoriasis patients treated with cyclosporin

Kidney International

Volumn 46, Issue 4, 1994, Pages 1216-1222

  Young, Eric W ^b   Ellis, Charles N ^b   Messana, Joseph M ^b   Johnson, Kent J ^b   Leichtman, Alan B ^b   Mihatsch, Michael J ^b   Hamilton, Ted A ^b   Groisser, Daniel S ^b   Fradin, Mark S ^b   Voorhees, John J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; IOTALAMIC ACID;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS;

EID: 0028046793     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1994.387     Document Type: Article

References (25)

1. KAHAN BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
2. ELLIS CN, FRADIN MS, MESSANA JM, BROWN MD, SIEGEL MT, HARTLEY AH, ROCHER LL, WHEELER S, HAMILTON TA, PARISH TG, ELLIS-MADU M, DUELL E, AMNESLEY TM, COOPER KD, VOORHEES JJ: Cyclosporine for plaque-type psoriasis: Results of a multidose, double-blind trial. N Engl J Med 324:277-284, 1991
3. MIHATSCH MJ, THIEL G, RYFFEL B: Histopathology of cyclosporine nephrotoxicity. Transplant Proc 20(Suppl 3):759-771, 1988
4. MIHATSCH MJ, THIEL G, BASLER V, RYFFEL B, LANDMANN J, VON OVERBECK J, ZOLLINGER HU: Morphological patterns in cyclosporine-treated renal transplant recipients. Transplant Proc 17:101-116, 1985
5. AUSTIN HA III, MUENZ LR, JOYCE KM, ANTONOVYCH TA, KULLICK ME, KLIPPEL JH, DECKER JL, BALOW JE: Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 75:382-391, 1983
6. INTERNATIONAL KIDNEY BIOPSY REGISTRY OF CYCLOSPORIN A (SANDIMMUN) IN AUTOIMMUNE DISEASES: Kidney biopsies in control or cyclosporin A-treated psoriatic patients. Br J Dermatol 122(Suppl 36):95-100, 1990
7. 125I-iothalamate. Kidney Int 4:346-349, 1973
8. BOLTON S: Pharmaceutical Statistics: Practical and Clinical Applications (2nd ed), New York, Marcel Decker, Inc., 1990, p. 494
9. ANNESLEY T, MATZ K, CLAYTON L, GIACHERIO D: Liquid-chromatographic analysis for cyclosporine with use of a microbore column and small sample volume. Clin Chem 32:1407-1409, 1986
10. MYERS BD, ROSS J, NEWTON L, LUETSCHER J, PERLROTH M: Cyclosporine-associated chronic nephropathy. N Engl J Med 311:699-704, 1984
11. SVENSON K, BOHMAN S-O, HÄLLGREN R: Renal interstitial fibrosis and vascular changes: Occurrence in patients with autoimmune diseases treated with cyclosporin. Arch Intern Med 146:2007-2010, 1986
12. PALESTINE AG, AUSTIN HA, BALOW JE, ANTONOVYCH TT, SABNIS SG, PREUSS HG, NUSSENBLATT RB: Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 314:1293-1298, 1986
13. DERAY G, BENHIMIDA M, LE HOANG P, MAKSUD P, AUPETIT B, BAMELOU A, JACOBS C: Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis. Ann Intern Med 117:578-583, 1992
14. GREENBERG A, EGEL JW, THOMPSON ME, HARDESTY RL, GRIFFITH BP, BAHNSON HT, BERNSTEIN RL, HASTILLO A, HESS ML, PUSCHETT JB: Early and late forms of cyclosporine nephrotoxicity: Studies in cardiac transplant recipients. Am J Kidney Dis 9:12-22, 1987
15. ZACHARIAE H, HANSEN HE, KRAGBALLE K, OLSEN S: Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol 26:415-419, 1992
16. LINDEMAN RD, TOBIN JD, SHOCK NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26:861-868, 1984
17. WALKER WG, NEATON JD, CUTLER JA, NEUWIRTH R, COHEN JD: Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. JAMA 268:3085-3091, 1992
18. POWLES AV, COOK T, HULME B, BAKER BS, LEWIS HM, THOMAS E, VALDIMARSSON H, FRY L: Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis. Br J Dermatol 128:159-165, 1993
19. FEUTREN G, MIHATSCH MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660, 1992
20. GILBERT SC, EMMETT M, MENTER A, SILVERMAN A, KLINTMALM G: Cyclosporine therapy for psoriasis: Serum creatinine measurements are an unreliable predictor of decreased renal function. J Am Acad Dermatol 21:470-474, 1989
21. POWLES AV, CARMICHAEL D, HULME B, THOMAS E, MCFADDEN J, BAKER B, VALDIMARSSON H, FRY L: Renal function after long-term low-dose cyclosporin for psoriasis. Br J Dermatol 122:665-669, 1990
22. KORSTANJE MJ, BILO HJG, STOOF TJ: Sustained renal function loss in psoriasis patients after withdrawal of low-dose therapy. Br J Dermatol 127:501-504, 1992
23. MARGOLIS DJ, GUZZO C, JOHNSON J, LAZARUS GS: Alterations in renal function in psoriasis patients treated with cyclosporine, 5 mg/kg/day. J Am Acad Dermatol 195-197, 1992
24. ELZINGA LW, ROSEB S, BENNETT WM: Dissociation of glomerular filtration rate from tubulinterstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 4:214-221, 1993
25. SCHAINUCK LI, STRIKER GE, CUTLER RE, BENDITT EP: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1:631-641, 1970